- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Revolution Medicines Inc (RVMD)
Revolution Medicines Inc stock price live, this page displays NASDAQ RVMD stock exchange data. View the RVMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Revolution Medicines Inc real time stock price chart below.
What Is the Revolution Medicines Inc Stock Price Today?
The Revolution Medicines Inc stock price today is 35.00.
What Is the Stock Symbol for Revolution Medicines Inc?
The stock symbol for Revolution Medicines Inc is ""RVMD.""
What Stock Exchange Does Revolution Medicines Inc Trade On?
Revolution Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Revolution Medicines Inc a Good Stock to Buy?
Determining whether Revolution Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVMD quote. (ISIN: US76155X1000)
What Is the Revolution Medicines Inc Stock Price Today?
The Revolution Medicines Inc stock price today is 35.00.
What Is the Stock Symbol for Revolution Medicines Inc?
The stock symbol for Revolution Medicines Inc is ""RVMD.""
What Stock Exchange Does Revolution Medicines Inc Trade On?
Revolution Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Revolution Medicines Inc a Good Stock to Buy?
Determining whether Revolution Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVMD quote. (ISIN: US76155X1000)
35.00
+0.05(+0.14%)
Closed·
After Hours
34.50-0.50(-1.43%)
·
Fair Value
An estimate of a Revolution Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.31
35.93
52 wk Range
29.17
62.40
RVMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
RVMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Revolution Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.3135.93
52 wk Range
29.1762.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RVMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Revolution Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
72.08
Upside
+105.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Revolution Medicines Inc Company Profile
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company’s RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Revolution Medicines Inc SWOT Analysis
RAS Inhibitor Pionee | Revolution Medicines leads in RAS-dependent cancer therapies, with promising candidates like RMC-6236 and RMC-9805 showing potential in PDAC and NSCLC treatments |
Clinical Milestones | Upcoming Phase 1 trials for PDAC and NSCLC in 2024-2025 could significantly impact the company's market position and validate its innovative approach |
Financial Health | Despite operating losses, RVMD maintains a strong cash position. Analyst price targets range from $60 to $87, reflecting optimism about future prospects |
Market Opportunities | Revolution Medicines' focus on unmet needs in cancer treatment and potential for combination therapies could drive growth in the competitive oncology market |
Revolution Medicines Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of -$1.31 missed forecast of -$1.12; revenue of $0 against expected $30.59 million
- Stock fell 4.48% after-hours to $36.67; company maintains FAIR financial health score of 2.17/5
- R&D expenses rose to $224.1 million, G&A to $40.6 million; $2.1 billion cash and investments on hand
- Full-year 2025 GAAP net loss guidance updated to $1.03-$1.09 billion; advancing G12V inhibitor development
- CEO emphasizes commitment to RAS-targeted therapies despite financial challenges and market competition
Last Updated: 07/08/2025, 08:48
Read Full TranscriptCompare RVMD to Peers and Sector
Metrics to compare | RVMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRVMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.1x | −4.0x | −0.5x | |
PEG Ratio | 0.30 | −0.01 | 0.00 | |
Price/Book | 3.5x | 2.5x | 2.6x | |
Price / LTM Sales | - | 150.6x | 3.3x | |
Upside (Analyst Target) | 108.2% | 196.4% | 43.5% | |
Fair Value Upside | Unlock | 6.5% | 6.8% | Unlock |
Analyst Ratings
13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 72.08
(+105.95% Upside)
Earnings
Latest Release
Aug 06, 2025
EPS / Forecast
-1.31 / -1.12
Revenue / Forecast
-- / 30.59M
People Also Watch
FAQ
What Stock Exchange Does Revolution Med Trade On?
Revolution Med is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Revolution Med?
The stock symbol for Revolution Med is "RVMD."
What Is the Revolution Med Market Cap?
As of today, Revolution Med market cap is 6.54B.
What Is Revolution Med's Earnings Per Share (TTM)?
The Revolution Med EPS (TTM) is -4.53.
When Is the Next Revolution Med Earnings Date?
Revolution Med will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is RVMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Revolution Med Stock Split?
Revolution Med has split 0 times.
How Many Employees Does Revolution Med Have?
Revolution Med has 534 employees.
What is the current trading status of Revolution Med (RVMD)?
As of 09 Aug 2025, Revolution Med (RVMD) is trading at a price of 35.00, with a previous close of 34.95. The stock has fluctuated within a day range of 34.31 to 35.93, while its 52-week range spans from 29.17 to 62.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.